The estimated Net Worth of Daniel A Carestio is at least $13.1 Milión dollars as of 6 October 2020. Mr. Carestio owns over 13,500 units of Steris Plc stock worth over $9,637,377 and over the last 9 years he sold STE stock worth over $1,058,051. In addition, he makes $2,425,840 as Chief Operating Officer a Senior Vice President at Steris Plc.
Sign up
Mr. Carestio STE stock SEC Form 4 insiders trading
Daniel has made over 10 trades of the Steris Plc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 13,500 units of STE stock worth $1,040,445 on 6 October 2020.
The largest trade he's ever made was exercising 15,000 units of Steris Plc stock on 18 September 2020 worth over $1,045,800. On average, Daniel trades about 1,948 units every 45 days since 2015. As of 6 October 2020 he still owns at least 39,814 units of Steris Plc stock.
You can see the complete history of Mr. Carestio stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Daniel Carestio biography
Daniel A. Carestio serves as Chief Operating Officer, Senior Vice President of the Company. He assumed this role in August 2018. From February 2018 to August 2018 he served as Senior Vice President, Sterilization and Disinfection. From August 2015 to February 2018, he served as Senior Vice President, STERIS Applied Sterilization Technologies and Life Sciences. From 2011 to August 2015, he served as Vice President, Sales and Marketing for Isomedix Services and General Manager of Life Sciences.
What is the salary of Daniel Carestio?
As the Chief Operating Officer a Senior Vice President of Steris Plc, the total compensation of Daniel Carestio at Steris Plc is $2,425,840. There are 3 executives at Steris Plc getting paid more, with Walter Rosebrough having the highest compensation of $6,458,640.
How old is Daniel Carestio?
Daniel Carestio is 47, he's been the Chief Operating Officer a Senior Vice President of Steris Plc since 2018. There are 19 older and 2 younger executives at Steris Plc. The oldest executive at Steris Plc is David Lewis, 76, who is the Independent Director.
What's Daniel Carestio's mailing address?
Daniel's mailing address filed with the SEC is C/O 70 SIR JOHN ROGERSON'S QUAY, , DUBLIN, L2, 2.
Insiders trading at Steris Plc
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough a John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
What does Steris Plc do?
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
What does Steris Plc's logo look like?
Complete history of Mr. Carestio stock trades at Steris Plc
Steris Plc executives and stock owners
Steris Plc executives and other stock owners filed with the SEC include:
-
Walter Rosebrough,
President, Chief Executive Officer, Director -
Walter M. Rosebrough Jr.,
CEO Emeritus & Sr. Advisor -
Michael Tokich,
Chief Financial Officer, Senior Vice President -
Daniel Carestio,
Chief Operating Officer, Senior Vice President -
J. Adam Zangerle,
Senior Vice President, General Counsel, Secretary -
Daniel A. Carestio,
Pres, CEO & Director -
Cary Majors,
Vice President - North America Commercial Operations -
Michael J. Tokich,
Sr. VP & CFO -
John Adam Zangerle,
Sr. VP, Gen. Counsel, Sec. -
Cary L. Majors,
Sr. VP of North America Commercial Operations -
Mohsen Sohi,
Independent Chairman of the Board -
David Lewis,
Independent Director -
Jacqueline Kosecoff,
Independent Director -
Richard Steeves,
Independent Director -
Richard Breeden,
Independent Director -
Loyal Wilson,
Independent Director -
Nirav Shah,
Independent Director -
Cynthia Feldmann,
Independent Director -
Duncan Nichol,
Independent Director -
Michael Wood,
Independent Director -
Christopher Holland,
Director -
Renato Tamaro,
Vice President and Corporate Treasurer -
Renato G. Tamaro,
VP & Corp. Treasurer -
Julia K. Madsen,
Sr. VP of Life Sciences -
Mary Clare Fraser,
VP & Chief HR Officer -
Julie Winter,
VP of Investor Relations & Corp. Communications -
Karen L. Burton,
Chief Accounting Officer, VP & Controller -
Esther M. Alegria,
Director -
Kathleen Bardwell,
Sr.V. P. & C.C.O. -
Sudhir K Pahwa,
Sr. V.P., IPT -
Suzanne V Forsythe,
V. P. - Human Resources -
Gulam Amjad Khan,
Sr. V.P., Procedural Solutions -
Adrian Vincent Coward,
Sr. V. P., Healthcare Services -
John P Wareham,
Director -
Michiel De Zwaan,
V.P., Human Resources & CHRO -
Kevin M Mcmullen,
Director -
Mary Clare Fraser,
SVP & Chief HRO -
Julia Madsen,
Senior VP, Life Sciences -
Paul Edward Martin,
Director -
Andrew Xilas,
SVP and GM, Dental -
Kenneth E Kohler,
SVP & GM, AST -
Karen L Burton,
VP & CAO